Business

PDMR Participation in SAYE Scheme

PDMR Participation in SAYE Scheme.

articleCambridge Nutritional Sciences PlcOctober 18, 20175/company/cambridge-nutritional-sciences-plc/news/pdmr-participation-in-saye-scheme
PDMR Participation in SAYE Scheme

About this update from Cambridge Nutritional Sciences Plc

[{"type":"text","content":"\n \nRNS Number : 9229T Omega Diagnostics Group PLC 18 October 2017  \n\n \nOmega Diagnostics Group PLC\n(\"Omega\" or the \"Company\")\n \nPDMR participation in SAYE scheme\n \nOmega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option awards in the Company's save as you earn scheme (\"SAYE Scheme\") which gives them the opportunity to participate in the future growth of the Company via share award arrangements. \n \nThe SAYE Scheme grants participants the option to purchase ordinary shares of 4 pence each in the capital of the Company (\"Ordinary Share\") at a price of 18.4 pence per Ordinary Share and is exercisable between 1 November 2020 and 1 May 2021.\n \nAccordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):\n \n\n\n\n\n1)\n\n\nDetails of Persons Discharging Managerial Responsibilities \"PDMR\" / person closely associated with them ('PCA')\n\n\n\n\na)\n\n\nName\n\n\nJohn Bannister\n\n\n\n\n2.\n\n\nReason for notification\n\n\n\n\nb)\n\n\nPosition / status\n\n\nPDMR\n\n\n\n\nc)\n\n\nInitial notification / amendment\n\n\nInitial Notification\n\n\n\n\n3.\n\n\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor\n\n\n\n\nb)\n\n\nName\n\n\nOmega Diagnostics Group plc\n\n\n\n\nc)\n\n\nLEI\n\n\n2138007U9P4BTZTYIR92\n\n\n\n\n4.\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n\n\nDescription of the financial instrument\n Identification code\n \n\n\nOptions over ordinary shares of 4p each\n \nGB00B1VCP282\n\n\n\n\nb)\n\n\nNature of the transaction\n\n\nGrant of share options under the Company's SAYE Scheme\n\n\n\n\nc)\n\n\nPrice(s) and volume(s)\n\n\n \n\n\n\n\nPrice(s)\n\n\nVolume(s)\n\n\n\n\n£0.184\n\n\n23,478\n \n\n\n\n\n \n\n\n\n\nd)\n\n\nAggregated information\nAggregated volume Price\n\n\nn/a\n\n\n\n\ne)\n\n\nDate of the transaction\n\n\n18 October 2017\n\n\n\n\nf)\n\n\nPlace of the transaction\n\n\nOutside a trading venue\n\n\n\n\n...

More updates from Cambridge Nutritional Sciences Plc